London, UK (PRWEB) January 10, 2012
Forecasts say that by the end of 2016 the world pharmaceutical market will approach around USD 1.6 trillion at retail prices, with high growth in emerging markets leveraging slow growth in developed ones. Market demand for more effective products coupled with the expanded health care access due to increasing generic penetration will be among the major contributors to this market growth.
The USA will continue to be the first worldwide economy, with other emerging markets including China, India, Russia and Brazil performing also well. Though, a second wave of emerging markets will arise, namely South Korea, Mexico, Turkey, Indonesia and Poland.
New market research report package “The Outlook for Pharmaceuticals Worldwide” worked out by Espicom Business Intelligence has been recently published by Market Publishers Ltd.
Report Package Details:
Title: The Outlook for Pharmaceuticals Worldwide
Published: January, 2012
Price: US$ 17,490
The market research report package provides critical business insights into the prospects for, and risks in, key established and emerging pharmaceutical markets across 63 countries of the globe.
A comprehensive report for each individual country’s pharmaceutical market is updated every three months. Moreover, comprehensive healthcare statistical intelligence is provided annually.
Report Package Contents:
The Outlook for Pharmaceuticals in Central and Eastern Europe
The Outlook for Pharmaceuticals in Northern Europe
The Outlook for Pharmaceuticals in Western Europe
The Outlook for Pharmaceuticals in Central Asia
The Outlook for Pharmaceuticals in South East Asia
The Outlook for Pharmaceuticals in North East Asia
The Outlook for Pharmaceuticals in Latin America
E7: The Outlook for Pharmaceuticals
The Market for Pharmaceuticals in Brazil, Russia, India & China
More new market report packages and individual market reports by the publisher can be found at Espicom Business Intelligence page.